Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Scipher Medicine

Scipher Medicine Launches ClinicalTrialRank.com: A Breakthrough AI Platform to Predict Clinical Trial Failure and Revolutionize Drug Development Investment Strategy
From Scipher Medicine
Via Business Wire
Scipher and Savant Bio Partner to Build the Most Comprehensive Clinico-Genomic Dataset in Rheumatoid Arthritis
From Scipher Medicine
Via Business Wire
Scipher Medicine Unveils New Tool to Predict Rheumatoid Arthritis Treatment Success at EULAR 2025
From Scipher Medicine
Via Business Wire
Scipher Medicine expands its global presence, bringing precision medicine to Latin America through an alliance with Grupo Amarey
From Scipher Medicine
Via Business Wire
Scipher Medicine Announces Collaboration with Top-Three Pharmaceutical Company to Integrate Precision Medicine into Clinical Trial Design
From Scipher Medicine
Via Business Wire
Scipher Medicine and Kythera Labs Partner to Unlock New Insights into Autoimmune Disease-Specific Treatment
From Scipher Medicine
Via Business Wire
Scipher Medicine and Roivant Partner to Bring Precision Medicine Insights to Rheumatology Drug Discovery and Development
From Scipher Medicine
Via Business Wire
Scipher Medicine® Launches a New Approach to Discover Treatment-Response-Predicting Biomarkers for Complex Diseases
From Scipher Medicine
Via Business Wire
Scipher Medicine® Showcases New Data at EULAR 2024
From Scipher Medicine
Via Business Wire
Dr. Reginald Seeto Appointed as CEO and President, to Lead Scipher Medicine's Next Phase of Growth
From Scipher Medicine
Via Business Wire
Scipher Medicine Signs Multi-Target Partnership with Ionis
From Scipher Medicine
Via Business Wire
Scipher Medicine Acquires CrossBridge and its SaaS Platform to Collect and Map Patient Molecular, Outcomes and Claims Data in Real Time
From Scipher Medicine
Via Business Wire
Scipher Medicine Announces Publication of Positive Results From AIMS Clinical Study
From Scipher Medicine
Via Business Wire
Galapagos In-licenses Novel Drug Targets for Inflammatory Bowel Disease Discovered by Scipher Medicine’s Spectra™ Platform
From Scipher Medicine
Via Business Wire
Scipher Medicine Publishes New Data Further Supporting Clinical Utility of PrismRA Blood Test
From Scipher Medicine
Via Business Wire
Scipher Medicine Closes $110 Million Financing
From Scipher Medicine
Via Business Wire
Scipher Medicine to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
From Scipher Medicine
Via Business Wire
Scipher Medicine Announces Publication of Real-World Study Demonstrating Clinical Utility of PrismRA® Blood Test
From Scipher Medicine
Via Business Wire
Scipher Medicine Leadership to Present at the 40th Annual J.P. Morgan Healthcare Conference
From Scipher Medicine
Via Business Wire
Scipher Medicine Appoints Richard Blackburn to its Advisory Board
From Scipher Medicine
Via Business Wire
Nearly 15% of Prescribing U.S. Rheumatologists Use Scipher Medicine’s PrismRA® Blood Test Since Its Launch A Year Ago
From Scipher Medicine
Via Business Wire
Scipher Medicine Appoints Dr. Michael Elliott to its Science Advisory Board
From Scipher Medicine
Via Business Wire
Scipher Medicine® Appoints Sam Asgarian, M.D., MBA Chief Medical Officer
From Scipher Medicine
Via Business Wire
RxParadigm Partners with Scipher Medicine® to Support Medication Utilization, Improve Patient Outcomes, and Lower Costs for Rheumatoid Arthritis Care
From Scipher Medicine
Via Business Wire
Scipher Medicine® to Present at the Jeffries London Healthcare Conference
From Scipher Medicine
Via Business Wire
Scipher Medicine® to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
From Scipher Medicine
Via Business Wire
GNS Healthcare and Scipher Medicine® Collaborate to Develop World’s First in silico Patient for Rheumatoid Arthritis
From Scipher Medicine
Via Business Wire
TARA Biosystems Partners with Scipher Medicine®
From Scipher Medicine
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.